Market Chatter: MediLink Therapeutics Taps CICC, JPMorgan, Morgan Stanley for Hong Kong IPO

MT Newswires Live

2025/06/12

MediLink Therapeutics has appointed China International Capital Corp, JPMorgan Chase, and Morgan Stanley for a planned IPO in Hong Kong, Bloomberg News reported Wednesday, citing people familiar with the matter.

The Suzhou, China-based biotechnology firm is targeting a raise of over $100 million, though discussions are still ongoing and terms may change, the report said.

MediLink, JPMorgan, and Morgan Stanley declined to comment, while CICC did not respond, Bloomberg said.

Founded in 2020, MediLink is a clinical-stage biotech company that focuses on antibody drugs, with research and development sites in Shanghai and Boston, the report added.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2542902568"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2542902568\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2542902568?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-12 11:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2542902568","market":"nz","top_or_hot":-1,"title":"Market Chatter: MediLink Therapeutics Taps CICC, JPMorgan, Morgan Stanley for Hong Kong IPO","media":"MT Newswires Live","content":"<html><body><p> MediLink <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> has appointed China International Capital Corp, JPMorgan Chase, and <a href=\"https://laohu8.com/S/MSSXV\">Morgan Stanley</a> for a planned IPO in Hong Kong, Bloomberg News reported Wednesday, citing people familiar with the matter.</p><p>The Suzhou, China-based biotechnology firm is targeting a raise of over $100 million, though discussions are still ongoing and terms may change, the report said.</p><p>MediLink, JPMorgan, and Morgan Stanley declined to comment, while CICC did not respond, Bloomberg said.</p><p>Founded in 2020, MediLink is a clinical-stage biotech company that focuses on antibody drugs, with research and development sites in Shanghai and Boston, the report added.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market Chatter: MediLink Therapeutics Taps CICC, JPMorgan, Morgan Stanley for Hong Kong IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket Chatter: MediLink Therapeutics Taps CICC, JPMorgan, Morgan Stanley for Hong Kong IPO\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-06-12 11:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> MediLink <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> has appointed China International Capital Corp, JPMorgan Chase, and <a href=\"https://laohu8.com/S/MSSXV\">Morgan Stanley</a> for a planned IPO in Hong Kong, Bloomberg News reported Wednesday, citing people familiar with the matter.</p><p>The Suzhou, China-based biotechnology firm is targeting a raise of over $100 million, though discussions are still ongoing and terms may change, the report said.</p><p>MediLink, JPMorgan, and Morgan Stanley declined to comment, while CICC did not respond, Bloomberg said.</p><p>Founded in 2020, MediLink is a clinical-stage biotech company that focuses on antibody drugs, with research and development sites in Shanghai and Boston, the report added.</p><p>(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2542902568","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2542902568","pubTimestamp":1749697248,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"MediLink Therapeutics has appointed China International Capital Corp, JPMorgan Chase, and Morgan Stanley for a planned IPO in Hong Kong, Bloomberg News reported Wednesday, citing people familiar with the matter.The Suzhou, China-based biotechnology firm is targeting a raise of over $100 million, though discussions are still ongoing and terms may change, the report said.MediLink, JPMorgan, and Morgan Stanley declined to comment, while CICC did not respond, Bloomberg said.Founded in 2020, MediLink is a clinical-stage biotech company that focuses on antibody drugs, with research and development sites in Shanghai and Boston, the report added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"513600":"恒生指数ETF南方","LENZ":"Therapeutics","03908":"中金公司","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","BK4539":"次新股","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","JPM":"摩根大通","BK4581":"高盛持仓","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","BK1516":"腾讯概念","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","02833":"恒指ETF","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU1732800096.USD":"摩根大通环球收益基金A (irc)","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","BK4127":"投资银行业与经纪业","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","SG9999002828.SGD":"Eastspring Investments Unit Trusts - Dragon Peacock A SGD","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","MS":"摩根士丹利","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","BK4516":"特朗普概念","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","BK1501":"阿里概念股","BK4588":"碎股","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","LU0106831901.USD":"贝莱德世界金融基金A2","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","HSI":"恒生指数","BK1564":"中资券商股","BK4007":"制药"},"translate_title":"市场热议：MediLink Therapeutics聘请中金公司、摩根大通、摩根士丹利在香港IPO","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"513600":0.6,"02833":0.6,"JPM":1,"HHImain":0.6,"HSI":0.9,"LENZ":1,"MCHmain":0.6,"03908":1,"MS":1,"MHImain":0.6},"content_text":"MediLink Therapeutics has appointed China International Capital Corp, JPMorgan Chase, and Morgan Stanley for a planned IPO in Hong Kong, Bloomberg News reported Wednesday, citing people familiar with the matter.The Suzhou, China-based biotechnology firm is targeting a raise of over $100 million, though discussions are still ongoing and terms may change, the report said.MediLink, JPMorgan, and Morgan Stanley declined to comment, while CICC did not respond, Bloomberg said.Founded in 2020, MediLink is a clinical-stage biotech company that focuses on antibody drugs, with research and development sites in Shanghai and Boston, the report added.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}